Dallas, TX -- (SBWIRE) -- 01/25/2011 -- GlobalData, the industry analysis specialist’s new report, “Glaucoma – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Glaucoma: Market Characterization
2.1 Overview
2.2 Glaucoma Market Size
2.3 Glaucoma Market Forecast and CAGR
2.4 Drivers and Barriers for the Glaucoma Market
2.4.1 Drivers of the Glaucoma Market
2.4.2 Barriers for the Glaucoma Market
2.5 Opportunity and Unmet Need
2.6 Key Takeaway

3 Glaucoma Market: Competitive Assessment
3.1 Overview
3.2 Strategic Competitor Assessment
3.2.1 Xalatan
3.2.2 Cosopt
3.2.3 Alphagan P
3.2.4 Travatan Z
3.2.5 Lumigan
3.3 Key Takeaway

4 Glaucoma: Pipeline Assessment
4.1 Overview
4.2 Strategic Pipeline Assessment
4.2.1 Technology Trends Analytic Framework
4.3 Glaucoma Therapeutics – Promising Drugs under Clinical Development.
4.4 Drugs under Clinical Development
4.4.1 Tafluprost (Saflutan)
4.4.2 NCX-116 (Formerly PF-03187207)
4.4.3 Catioprost
4.5 Glaucoma Therapeutics Market – Clinical Pipeline by Mechanism of Action
4.6 Glaucoma Pipeline – Pipeline by Phase of Clinical Development
4.6.1 Glaucoma Therapeutics – Phase III Clinical Pipeline
4.6.2 Glaucoma Therapeutics – Phase II Clinical Pipeline
4.6.3 Glaucoma Therapeutics – Phase I Clinical Pipeline
4.6.4 Glaucoma Therapeutics – Preclinical Pipeline
4.6.5 Glaucoma Therapeutics – Discovery Pipeline
4.7 Discontinued / Suspended Drugs for Glaucoma
4.8 Key Takeaway

5 Glaucoma Market: Implications for Future Market Competition

6 Glaucoma Market: Future Players in the Glaucoma Market
6.1 Introduction
6.2 NicOx SA and Bausch and Lomb
6.2.1 Overview
6.2.2 Business Description
6.2.3 Ophthalmology Portfolio
6.2.4 Glaucoma Product Portfolio
6.3 Novagali Pharma SA
6.3.1 Overview
6.3.2 Business Description
6.3.3 Glaucoma Product Portfolio
6.4 Merck (MSD) and Santen Pharmaceuticals, Japan
6.4.1 Overview
6.4.2 Business Description
6.4.3 Glaucoma Product Portfolio

7 Glaucoma Market: Appendix
7.1 Definitions
7.2 Acronyms
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasting
7.3.4 Primary Research
7.3.5 Expert Panels
7.4 Contact Us
7.5 Disclaimer
7.6 Sources
Buy Now : Market Research
http://www.reportsnreports.com/
Related Reports
Head and Neck Cancer – Drug Pipeline Analysis and Market Forecasts to 2016
Amyotrophic Lateral Sclerosis (Lou Gehrig’s) – Drug Pipeline Analysis and Market Forecasts to 2016
Erectile Dysfunction – Drug Pipeline Analysis and Market Forecasts to 2016
Tuberculosis – Drug Pipeline Analysis and Market Forecasts to 2016
Hepatitis B – Drug Pipeline Analysis and Market Forecasts to 2016
Candidiasis – Drug Pipeline Analysis and Market Forecasts to 2016
Acne – Drug Pipeline Analysis and Market Forecasts to 2016
Herpes Simplex – Drug Pipeline Analysis and Market Forecasts to 2016
Stomach Cancer – Drug Pipeline Analysis and Market Forecasts to 2016
Hepatitis C – Drug Pipeline Analysis and Market Forecasts to 2016

About ReportsnReports
ReportsnReports comprises of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.